reviewWorld Journal of GastroenterologyAug 9, 2022HYBRID OA

Gut microbiota, inflammatory bowel disease and colorectal cancer

Universidade Estadual Paulista (Unesp)

PubMed
Indexed incrossrefpubmed

Abstract

, and ETBF. Future research can evaluate the advantages of modulating the gut microbiota as preventive measures in CRC high-risk patients, directly affecting the prognosis of the disease and the quality of life of patients.

Citation impact

429
total citations
FWCI
34.65
Percentile
100%
References
47
Citations per year

Authors

5

Topics & keywords

Keywords
  • Dysbiosis
  • Inflammatory bowel disease
  • Bacteroides fragilis
  • Gut flora
  • Ulcerative colitis
  • Colorectal cancer
  • Microbiome
  • Irritable bowel syndrome
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.